New study investigates autism spectrum disorder prevalence
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that includes a variety of differences or challenges with social communication and interaction, restricted interests, repetitive behaviour, and sensory processing differences. A new report from the US Centers for Disease Control and Prevention (CDC) in 16 sites across the US has found that rates of ASD in children aged between four and eight years were higher in 2022 than in previous years. This study adds data to support the trend of an increasing prevalence of ASD across the US, but the study found the situation was more complex than simply rising prevalence rates.
This study found that in 2022, the observed prevalence of ASD was 32.2 per 1,000 children, meaning that approximately 1 in 31 children had ASD, a notably higher estimate than that of 2020 (26.1 per 1,000 children). The prevalence varied widely across sites in this study, with the highest prevalence observed in the California study site. Race and sex were also investigated, and a higher prevalence of ASD was seen in Asian/Pacific Islander (A/PI), Black, and Hispanic children than in White children. Additionally, the prevalence was higher, as observed in previous studies, in boys than in girls across all study sites.
The study also investigated why the prevalence of ASD in young children appears to have increased between 2020 and 2022. Since the last study period, the screening rate for ASD in young children has increased, in large part due to campaigns toeducate medical professionals who work with previously underserved communities. Increased screening, especially in low-income, A/PI, Black, and Hispanic communities, has resulted in improved case detection and higher prevalence rates.
In the US, GlobalData epidemiologists have noted an increase in diagnosed prevalent cases, with a forecasted increase from approximately 3,207,000 cases in 2025 to 3,267,000 cases in 2031. This increase is observed across all ethnic groups. Total prevalent cases of ASD, which include cases that are both diagnosed and currently not diagnosed, are expected to increase from approximately five million in 2025 to 5.1 million by 2031.
This study is released against a backdrop of concern for increasing ASD rates across the US. It is important to note that while the study only comments on changes between 2020 and 2022 in ASD prevalence, there is a longer trend of increasingprevalence of ASD lasting nearly two decades. This is in part due to changes in the definition of ASD, which was formerly called 'autism,' to include a broader variety of disorders under the umbrella term ASD. Changes in definition, combined with increased screening and awareness, contribute chiefly to the increase in prevalence of ASD in this age group. This supposition is further supported by studies investigating the subgroup of children who have high support needs, including 24-hour-a-day support and care, limited verbal communication, and intellectual disability co-occurring with autism. The rates of this subtype of ASD have increased only very slightly, if at all, over the last ten years. So, while ASD diagnosis and prevalence are on the rise, it is important to keep in mind that the primary use of this information must be meeting the needs of these children and ensuring that all children are given the support they need to reach their full potential.
"New study investigates autism spectrum disorder prevalence" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
An Optometrist Shared The One Eye Product We Should All Stop Using
Eye health is often overlooked. Tons of Americans skip their annual eye exams: Of those who are considered to be at high risk for vision loss, which is roughly 4 in 10 Americans, 40% didn't get their eyes checked out in the past year, according to the Centers for Disease Control and Prevention. 'It's not until you have [a] problem with your eyes that you really become grateful for your vision,' said Dr. Michelle Holmes, an optometrist at Pacific Neuroscience Institute in Santa Monica, California. There's a lot you can do to protect your eye health. You can keep up with your annual eye exams, wear sunglasses to shield your eyes from the sun's harmful ultraviolet rays, and avoid wearing contacts to bed or in the pool, to name a few. But is there one habit you should never do, even though it may seem like eye care: Don't use eye-whitening, or red-eye relieving, drops. 'My concern with those types of eye drops is that eye-whitening drops can be used by someone to mask redness, and, oftentimes, that redness is a symptom of some more serious underlying condition,' Holmes told HuffPost. Here's why you may want to steer clear of redness relief eye drops. Related: If You Don't Pass This Extremely Easy Hygiene Test, You're Officially Stinkier Than The Average Human Related: It Turns Out That Most People Wipe Their Butts Completely Wrong, But This Doctor Is Here To Teach Us The Right Way When your eye is irritated, as it may be with pink eye or certain allergies, the blood vessels located in the front of the eye will dilate and engorge. 'That's what causes the white part of the eye to look red and angry,' Holmes explained. Those blood vessels serve an important purpose — when inflamed, they indicate something is wrong, Holmes said. This could be due to a mild problem, such as a cold or dust in the eye, or it may be a symptom of a more serious health condition like an infection, glaucoma or a corneal abrasion. 'It's not normal to have a red, angry-looking eye,' Holmes said. Red-eye relieving drops target these blood vessels to constrict and minimize their appearance. Temporarily, this makes the eyes white again, however, these drops could mask the problem at hand. 'It may make you think everything is OK with your eyes when really the can be something quite serious going on,' Holmes said. It's a bandaid, not a fix, she added. That redness can help your eye doctor detect eye diseases. With certain eye conditions, time is of the essence. Left untreated, they can worsen and lead to complications, including infections, and, in serious cases, vision loss. Not to mention, these drops may cause a rebound effect. 'As the eye drops wear off and nutrients and oxygen start to flow back through those blood vessels, they actually will dilate and engorge more than initially,' Holmes said. People can then get trapped in a cycle: their eyes appear red and irritated, they use redness-relieving drops that provide temporary relief, but then the redness comes back — this time, even worse — and they use the drops again. In some cases, people become dependent on red-eye relieving drops and the underlying health issue is never addressed, Holmes said. There are other remedies you can use instead. Whenever a patient tells Holmes they use eye-whitening drops, she recommends they opt for lubricating artificial tears instead. Her advice: use preservative-free drops — 'they're gentler on the eyes,' she explained. These products are generally thought to be the safest type of preservative-free eye drops. The Food and Drug Administration recently issued a warning against 26 over-the-counter eye drop products due to the risk of eye infections that may cause partial vision loss or blindness. Finally, if your eye is red and irritated, talk to an eye care provider. Even if you give your local eye clinic a call, the front desk should be able to triage the redness — and determine if you need follow-up care or testing — and recommend safe, effective eye drops. 'Oftentimes, the cause of the redness can be determined and more effectively addressed when the reason why is known,' Holmes article originally appeared on HuffPost. Also in Goodful: This Woman Is Going Viral For Begging Women Not To Get Married Right Now, And Personally, I Couldn't Agree More Also in Goodful: People Are Sharing Their Biggest "How Doesn't Everyone Know This?" Facts, And I'm Honestly Embarrassed I Never Realized Some Of These Also in Goodful: "I Thought This Was Normal": People Are Sharing Diagnoses They Received After Someone Else Pointed Out Their Symptoms
Yahoo
16 hours ago
- Yahoo
Member of RFK Jr's new vaccine panel withdraws over conflict of interest
A member of the health secretary Robert F Kennedy Jr's newly overhauled federal vaccine advisory panel withdrew after a conflict of interest review, a spokesperson has told the Guardian. Dr Michael Ross, who was involved in multiple private healthcare companies, withdrew after review of his financial holdings. Kennedy unilaterally fired all 17 members of the Centers for Disease Control and Prevention's (CDC) advisory committee on immunization practices (ACIP) in June, arguing they had too many conflicts of interest. Related: Who are the eight new vaccine advisers appointed by Robert F Kennedy? Ross was among eight of Kennedy's ideological allies appointed to the committee, after the secretary argued the old members of the committee were subject to too many conflicts of interest. 'Yesterday, Dr Michael Ross decided to withdraw from serving on ACIP during the financial holdings review,' a spokesperson for the Department of Health and Human Services (HHS) said. 'The sacrifice to serve on ACIP varies from member to member, and we appreciate Dr Ross's willingness to go through this rigorous process.' The spokesperson made the comments after Guardian inquiries about conflict of interest disclosures for new members of ACIP. Although the Trump administration and Kennedy developed a conflict of interest tracker specifically for ACIP members, Kennedy's appointees have not been added. The HHS spokesperson did not respond to Guardian inquiries about when and where new, written conflict of interest disclosures would be published. Instead, the spokesperson said the department has, 'comprehensively reviewed all newly appointed ACIP members for conflicts of interests in accordance with federal law, regulations and departmental polices', and that the members were provided 'ethics training prior to discharging their duties'. The new members of the committee were asked to disclose conflicts of interest before the meeting began on Wednesday. The committee chair Dr Martin Kulldorff and committee member Dr Robert Malone omitted widely reported work in vaccine litigation, and nurse Vicky Pebsworth said she was 'asked to read' a statement disclosed ownership of a healthcare stock but said it was below the government ethics office threshold for reporting. Ethics review of the new members was also the subject of Senate testimony on Wednesday. Under questioning by the Democratic senator Patty Murray of Washington, the Trump nominee to head the CDC, Dr Susan Monarez, said she was 'not familiar whether or not the members that are participating in the meeting this week have or have not gone through the ethics review necessary to allow them to participate in those meetings'. 'If it is known that they have not gone through the ethics process and they issue recommendations, would you accept them as valid?' asked Murray. 'If they have not gone through an ethics approval process, they shouldn't be participating in the meetings,' said Monarez.
Yahoo
16 hours ago
- Yahoo
RFK Jr's new vaccine panel votes against preservative in flu shots in shock move
A critical federal vaccine panel has recommended against seasonal influenza vaccines containing a specific preservative – a change likely to send shock through the global medical and scientific community and possibly impact future vaccine availability. The panel was unilaterally remade by health secretary Robert F Kennedy Jr, a vaccine skeptic who has urged against the use of thimerosal despite a lack of evidence of real-world harm. Across three votes, members voted in favor of restricting thimerosal in seasonal influenza vaccines across all age groups – with five in favor of the restriction, one abstention and one vote against. 'The risk from influenza is so much greater than the nonexistent – as far as we know – risk from thimerosal,' said Dr Cody Meissner, a panel member and professor of pediatrics at Dartmouth's Geisel School of Medicine who was the lone 'no' vote. 'I would hate for a person not to receive the influenza vaccine because the only availability preparation contains thimerosal – I find that very hard to justify.' The panel, formally called the Advisory Committee for Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC), is a critical link in the vaccine distribution pipeline – informing health insurers and clinicians alike about which vaccines to give patients. Kennedy fired all 17 former members of the panel in June, citing conflicts of interest, and appointed eight new members, all of whom are ideological allies of the secretary. None of the new members have published written conflict of interest disclosures or been added to a Trump administration-developed conflict of interest tracker for ACIP members, as of Thursday morning. 'There is a very big difference between what was shared at the meeting versus what is reality,' said Dr Sean O'Leary, chair of the American Academy of Pediatrics Committee on Infectious Diseases. 'The science on thimerosal is settled, and the rhetoric being used to suggest otherwise is misleading and harmful.' Rather than vote on an agenda that had once included seasonal recommendations for Covid-19 and the vaccine against human papilloma virus (HPV), ACIP added the controversial focus of thimerosal in vaccines. The panel affirmed that the influenza vaccine is recommended for Americans older than six months. Related: RFK Jr will be 'personally responsible' for children's deaths by halting vaccine alliance funding, experts say Although multiple studies have found no real-world harm, the preservative has been a talking point of anti-vaccine advocates for decades. Multiple representatives of physicians associations urged the panel to reject the recommendation against thimerosal in the meeting. Thimerosal is used in about 5% of multidose seasonal influenza vials, and is known to be more cost effective than single-dose formulations. It is unclear how the vote will impact flu vaccine availability before the upcoming flu season, particularly for clinics that rely on such formulations. Thimerosal has been used as a preservative in vaccines since before the second world war. In the early 2000s, thimerosal was removed from all routine pediatric and most adult vaccines as a precautionary measure – a decision that was criticized by experts who argued it sent mixed messages about a preservative that had not been found to cause harm. The issue has since been considered settled by mainstream medicine. Thimerosal is an ethylmercury-based preservative. Ethylmercury is different from the kind of mercury found in seafood, called methylmercury. Ethylmercury has a much shorter half-life in the blood and brain, about seven days and 30 days respectively, compared to methylmercury, which has an approximately 44-58 day half-life and accumulates in the brain. The amount of ethylmercury contained in a flu vaccine (25 micrograms) is about half of that contained in a 3-ounce serving of canned tuna fish (40 micrograms). Repeated, large studies conducted across several countries have found no association between thimerosal and neurological effects. A presentation from CDC career scientists that was initially expected to go through some of this substantial data was removed before the panel reconvened on Thursday. In response to a question about the slapped down presentation, ACIP member Dr Robert Malone, a well-known anti-vaccine activist, said: 'That article was not authorized by the office of the secretary and was removed.' The panel instead heard a presentation from Lyn Redwood, a nurse practitioner who founded the World Mercury Project, the predecessor to Kennedy's anti-vaccine advocacy group Children's Health Defense. Prior to the meeting, her presentation was found to include a reference to a study that appeared to be made up. 'This is an old issue that has been addressed in the past and there are many issues we could discuss,' said Meissner. The best public interest journalism relies on first-hand accounts from people in the know. If you have something to share on this subject you can contact us confidentially using the following methods. Secure Messaging in the Guardian app The Guardian app has a tool to send tips about stories. Messages are end to end encrypted and concealed within the routine activity that every Guardian mobile app performs. This prevents an observer from knowing that you are communicating with us at all, let alone what is being said. If you don't already have the Guardian app, download it (iOS/Android) and go to the menu. Select 'Secure Messaging'. SecureDrop, instant messengers, email, telephone and post See our guide at for alternative methods and the pros and cons of each. Responding to criticism of Redwood's presentation, ACIP chair Dr Martin Kulldorff, a former Harvard professor who was fired for refusing the Covid-19 vaccine, said: 'It's inappropriate to dismiss a presentation just because the person does not have a PhD or MD.' The decision from ACIP could have global implications, because vaccines used around the world rely on thimerosal as a preservative in multidose vials, which are less expensive. 'I know ACIP is focused on the US, but recommendations that the ACIP makes are followed among many countries around the world,' said Meissner. 'Removing thimerosal from all vaccines used in other countries, for example, is going to reduce access to these vaccines, it will increase costs, and I think it's important to note that no study has ever indicated any harm from thimerosal.'
